-
★
Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers
(Hinzugefügt: 10.04.2023 um 14:32 Uhr)
https://www.science.org/doi/10.1126/scitranslmed.adg2783
-
★
Evaluation of Three anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response
(Hinzugefügt: 04.08.2021 um 08:51 Uhr)
https://academic.oup.com/jalm/advance-article/doi/10.1093/jalm/jfab087/6331990
-
★
Anti-SARS-CoV-2 antibody levels are concordant across multiple platforms but are not fully predictive of sterilizing immunity
(Hinzugefügt: 04.05.2021 um 05:29 Uhr)
https://www.medrxiv.org/content/10.1101/2021.04.26.21256118v1
-
★
Antibody tests for identification of current and past infection with SARS‐CoV‐2
(Hinzugefügt: 30.11.2020 um 20:14 Uhr)
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013652/full
-
★
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect
(Hinzugefügt: 13.11.2020 um 08:37 Uhr)
https://www.sciencedirect.com/science/article/pii/S1386653220304054
-
Reduced sensitivity of commercial Spike-specific antibody assays after primary infection with the SARS-CoV-2 Omicron variant
(Hinzugefügt: 27.05.2022 um 07:42 Uhr)
https://www.researchsquare.com/article/rs-1669740/v1
-
Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
(Hinzugefügt: 30.04.2022 um 11:04 Uhr)
https://www.nature.com/articles/s41587-022-01280-8
-
Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19
(Hinzugefügt: 03.04.2022 um 17:07 Uhr)
https://www.frontiersin.org/articles/10.3389/fmed.2021.569266/full
-
Antikörper nach SARS-CoV-2-Infektion – neue Erkenntnisse über die Sensitivität und Nachweisdauer von Antikörpertests
(Hinzugefügt: 17.02.2022 um 05:54 Uhr)
https://www.pei.de/DE/newsroom/pm/jahr/2022/03-antikoerper-sars-cov-2-infektion-neue-erkenntnisse-sensitivitaet-nachweisdauer-antikoerpertests.html
-
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design
(Hinzugefügt: 17.02.2022 um 05:54 Uhr)
https://www.sciencedirect.com/science/article/pii/S138665322100319X
-
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects
(Hinzugefügt: 14.02.2022 um 16:17 Uhr)
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8621742/
-
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
(Hinzugefügt: 24.01.2022 um 19:45 Uhr)
https://www.mdpi.com/2076-393X/10/1/64
-
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
(Hinzugefügt: 22.01.2022 um 13:32 Uhr)
https://www.frontiersin.org/articles/10.3389/fimmu.2021.808932/full
-
Potential False-Positive and False-Negative Results for COVID-19 IgG/IgM Antibody Testing After Heat-Inactivation
(Hinzugefügt: 07.12.2021 um 19:33 Uhr)
https://www.frontiersin.org/articles/10.3389/fmed.2020.589080/full
-
New 10-minute test detects Covid-19 immunity
(Hinzugefügt: 07.12.2021 um 07:23 Uhr)
https://news.mit.edu/2021/smart-develops-10-minute-test-detect-covid-immunity-1122
-
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
(Hinzugefügt: 19.11.2021 um 15:43 Uhr)
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00267-6/fulltext
-
COVID-19: The older you are, the more antibodies you have
(Hinzugefügt: 09.11.2021 um 15:53 Uhr)
https://nouvelles.umontreal.ca/en/article/2021/11/08/covid-19-the-older-you-are-the-more-antibodies-you-have/
-
IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases
(Hinzugefügt: 12.10.2021 um 10:37 Uhr)
https://www.mdpi.com/1999-4915/13/10/1945
-
Predictors of Nonseroconversion after SARS-CoV-2 Infection
(Hinzugefügt: 15.09.2021 um 15:28 Uhr)
https://wwwnc.cdc.gov/eid/article/27/9/21-1042_article
-
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
(Hinzugefügt: 24.08.2021 um 17:17 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2782762
-
Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection
(Hinzugefügt: 24.08.2021 um 15:12 Uhr)
https://www.medrxiv.org/content/10.1101/2021.08.19.21262111v1
-
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
(Hinzugefügt: 07.08.2021 um 16:08 Uhr)
https://www.nature.com/articles/s41467-021-24979-9
-
Vaccine antibody levels start to wane at around 2-3 months
(Hinzugefügt: 03.08.2021 um 10:31 Uhr)
https://www.ucl.ac.uk/news/2021/jul/vaccine-antibody-levels-start-wane-around-2-3-months
-
Was bringen Antikörpertests?
(Hinzugefügt: 13.07.2021 um 07:06 Uhr)
https://www.faz.net/aktuell/politik/inland/neue-strategie-gefordert-was-bringen-antikoerpertests-17430846.html
-
Antikörpertests reichen für digitales COVID-19-Zertifikat vorerst nicht aus – aber das könnte sich ändern
(Hinzugefügt: 04.07.2021 um 06:05 Uhr)
https://www.aerzteblatt.de/nachrichten/125214/Antikoerpertests-reichen-fuer-digitales-COVID-19-Zertifikat-vorerst-nicht-aus-aber-das-koennte-sich-aendern
-
FDA greenlights its first saliva-based COVID-19 antibody test
(Hinzugefügt: 30.06.2021 um 15:28 Uhr)
https://www.fiercebiotech.com/medtech/fda-greenlights-its-first-saliva-based-covid-19-antibody-test
-
Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses
(Hinzugefügt: 30.06.2021 um 15:08 Uhr)
https://pubs.acs.org/doi/10.1021/acsnano.1c03972
-
A Next-Generation Rapid, Accurate SARS-CoV-2 Antibody Test
(Hinzugefügt: 15.05.2021 um 09:57 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2779848
-
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
(Hinzugefügt: 05.05.2021 um 10:36 Uhr)
https://science.sciencemag.org/content/early/2021/05/03/science.abg5268.full
-
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
(Hinzugefügt: 05.05.2021 um 08:15 Uhr)
https://www.biorxiv.org/content/10.1101/2021.05.02.442326v1
-
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
(Hinzugefügt: 02.05.2021 um 03:23 Uhr)
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(21)00191-8
-
Patterns of seroconversion for SARS-CoV-2 IgG in patients with malignant disease and association with anticancer therapy
(Hinzugefügt: 22.04.2021 um 12:53 Uhr)
https://www.nature.com/articles/s43018-021-00191-y
-
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
(Hinzugefügt: 21.04.2021 um 14:07 Uhr)
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00103-8
-
Antibody Responses in COVID-19: A Review
(Hinzugefügt: 17.04.2021 um 12:02 Uhr)
https://www.frontiersin.org/articles/10.3389/fimmu.2021.633184/full
-
Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19
(Hinzugefügt: 14.04.2021 um 06:53 Uhr)
https://www.frontiersin.org/articles/10.3389/fmed.2021.569266/full
-
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
(Hinzugefügt: 01.04.2021 um 18:58 Uhr)
https://www.nature.com/articles/s41467-021-22236-7
-
New $2 Test Can Accurately Detect COVID-19 Antibodies in a Drop of Blood in Less Than an Hour
(Hinzugefügt: 30.03.2021 um 08:29 Uhr)
https://scitechdaily.com/new-2-test-can-accurately-detect-covid-19-antibodies-in-a-drop-of-blood-in-less-than-an-hour/
-
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
(Hinzugefügt: 29.03.2021 um 18:26 Uhr)
https://www.nature.com/articles/s41467-021-22045-y
-
Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT
(Hinzugefügt: 29.03.2021 um 06:16 Uhr)
https://assets.researchsquare.com/files/rs-324548/v1/e38f6127-ac18-4104-b254-2c5daa2dad55.pdf
-
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
(Hinzugefügt: 25.03.2021 um 06:57 Uhr)
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00025-2/fulltext
-
Longitudinal determination of mRNA-vaccination induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of healthcare workers with and without prior exposure to the novel coronavirus
(Hinzugefügt: 25.03.2021 um 06:50 Uhr)
https://www.medrxiv.org/content/10.1101/2021.03.17.21253751v1
-
Association of Age With SARS-CoV-2 Antibody Response
(Hinzugefügt: 25.03.2021 um 06:28 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743
-
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab
(Hinzugefügt: 23.03.2021 um 15:50 Uhr)
https://gut.bmj.com/content/early/2021/03/19/gutjnl-2021-324388
-
Evidence for antibody as a protective correlate for COVID-19 vaccines
(Hinzugefügt: 23.03.2021 um 15:43 Uhr)
https://www.medrxiv.org/content/10.1101/2021.03.17.20200246v1
-
Association of Age With SARS-CoV-2 Antibody Response
(Hinzugefügt: 23.03.2021 um 04:10 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2777743?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032221
-
A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates
(Hinzugefügt: 19.03.2021 um 08:32 Uhr)
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00039-2
-
Clinical Significance of an IgM and IgG Test for Diagnosis of Highly Suspected COVID-19
(Hinzugefügt: 17.03.2021 um 01:56 Uhr)
https://www.frontiersin.org/articles/10.3389/fmed.2021.569266/abstract
-
A dual antibody test for accurate surveillance of SARS-CoV-2 exposure rates
(Hinzugefügt: 17.03.2021 um 01:48 Uhr)
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00039-2
-
COVID-19 serosurveys for public health decision making
(Hinzugefügt: 09.03.2021 um 13:08 Uhr)
https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00057-7/fulltext
-
Discrete SARS-CoV-2 antibody titers track with functional humoral stability
(Hinzugefügt: 25.02.2021 um 20:05 Uhr)
https://www.nature.com/articles/s41467-021-21336-8
-
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
(Hinzugefügt: 25.02.2021 um 19:44 Uhr)
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2776810
-
Age- and Sex-Associated Variations in the Sensitivity of Serological Tests Among Individuals Infected With SARS-CoV-2
(Hinzugefügt: 16.02.2021 um 11:33 Uhr)
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2776300
-
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing
(Hinzugefügt: 07.02.2021 um 10:17 Uhr)
https://www.idsociety.org/practice-guideline/covid-19-guideline-serology/
-
SARS-CoV-2: Der richtige Nachweis
(Hinzugefügt: 31.01.2021 um 13:06 Uhr)
https://www.aerzteblatt.de/archiv/213661/SARS-CoV-2-Der-richtige-Nachweis
-
Lessons in antiviral immunity
(Hinzugefügt: 31.01.2021 um 10:09 Uhr)
https://science.sciencemag.org/content/371/6528/464.full
-
Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients
(Hinzugefügt: 27.01.2021 um 09:38 Uhr)
https://pubmed.ncbi.nlm.nih.gov/32343415/
-
Evaluation of six commercial SARS-CoV-2 Enzyme-Linked Immunosorbent assays for clinical testing and serosurveillance.
(Hinzugefügt: 27.01.2021 um 09:35 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.21.21250249v1
-
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Ho
(Hinzugefügt: 27.01.2021 um 09:21 Uhr)
https://www.nejm.org/doi/10.1056/NEJMc2031364
-
B cell memory: Understanding COVID-19
(Hinzugefügt: 26.01.2021 um 09:34 Uhr)
https://www.cell.com/immunity/fulltext/S1074-7613(21)00037-6
-
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic COVID-19 patients
(Hinzugefügt: 20.01.2021 um 08:10 Uhr)
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(21)00004-5
-
WAS BRINGEN TESTS AUF ANTIKÖRPER GEGEN SARS-COV-2?
(Hinzugefügt: 18.01.2021 um 12:09 Uhr)
https://www.arznei-telegramm.de/html/2020_06/2006041_01.html
-
A Serology Strategy for Epidemiological Studies Based on the Comparison of the Performance of Seven Different Test Systems - The Representative COVID-19 Cohort Munich
(Hinzugefügt: 17.01.2021 um 17:59 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.13.21249735v1
-
Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients.
(Hinzugefügt: 17.01.2021 um 07:42 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.13.20249038v1
-
Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients
(Hinzugefügt: 13.01.2021 um 11:41 Uhr)
https://www.medrxiv.org/content/10.1101/2021.01.12.21249702v1
-
Detecting COVID-19 antibodies in 10-12 seconds
(Hinzugefügt: 09.01.2021 um 10:24 Uhr)
https://www.eurekalert.org/pub_releases/2021-01/coec-dc010721.php
-
COVID-19: Significance of antibodies
(Hinzugefügt: 04.01.2021 um 18:54 Uhr)
https://content.iospress.com/articles/human-antibodies/hab200429
-
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
(Hinzugefügt: 30.12.2020 um 11:55 Uhr)
https://www.nejm.org/doi/full/10.1056/NEJMoa2034545?query=TOC
-
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study
(Hinzugefügt: 22.12.2020 um 07:47 Uhr)
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30197-X/fulltext
-
Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays
(Hinzugefügt: 18.12.2020 um 10:21 Uhr)
https://www.future-science.com/doi/10.4155/bio-2020-0289
-
Are commercial antibody assays substantially underestimating SARS-CoV-2 ever infection? An analysis on a population-based sample in a high exposure setting
(Hinzugefügt: 15.12.2020 um 09:51 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.14.20248163v1
-
Ultra-Specific, Non-Invasive Saliva Test Enables Quantitative Testing Of COVID-19 Antibodies
(Hinzugefügt: 10.12.2020 um 10:07 Uhr)
https://www.labmedica.com/covid-19/articles/294786011/ultra-specific-non-invasive-saliva-test-enables-quantitative-testing-of-covid-19-antibodies.html
-
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralisation and commercial assays
(Hinzugefügt: 09.12.2020 um 18:53 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.08.20245811v1
-
IgG Antibodies against SARS-CoV-2 Correlate with Days from Symptom Onset, Viral Load and IL-10
(Hinzugefügt: 09.12.2020 um 00:21 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.05.20244541v1
-
Seroconversion stages COVID19 into distinct pathophysiological states
(Hinzugefügt: 09.12.2020 um 00:20 Uhr)
https://www.medrxiv.org/content/10.1101/2020.12.05.20244442v1
-
IgA dominates the early neutralizing antibody response to SARS-CoV-2
(Hinzugefügt: 08.12.2020 um 09:09 Uhr)
https://stm.sciencemag.org/content/early/2020/12/04/scitranslmed.abd2223.full
-
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
(Hinzugefügt: 08.12.2020 um 09:09 Uhr)
https://immunology.sciencemag.org/content/5/54/eabe0240.full
-
Behörde gibt grünes Licht für Verkauf von Coronaantikörpertest
(Hinzugefügt: 03.12.2020 um 18:27 Uhr)
https://www.aerzteblatt.de/nachrichten/119002/Behoerde-gibt-gruenes-Licht-fuer-Verkauf-von-Coronaantikoerpertest
-
Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data
(Hinzugefügt: 02.12.2020 um 09:44 Uhr)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0237548
-
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis
(Hinzugefügt: 01.12.2020 um 18:56 Uhr)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241164
-
Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay
(Hinzugefügt: 01.12.2020 um 07:58 Uhr)
https://www.medrxiv.org/content/10.1101/2020.11.27.20239590v1
-
Coronavirus antibody prevalence falling in England, REACT study show
(Hinzugefügt: 20.11.2020 um 08:21 Uhr)
https://www.imperial.ac.uk/news/207333/coronavirus-antibody-prevalence-falling-england-react/
-
COVID-19 Antibody Tests Perform Well in Head-to-Head Comparison
(Hinzugefügt: 15.11.2020 um 09:06 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2772739
-
Comparative Clinical Performance of Seven Commercial Serology Tests
(Hinzugefügt: 14.11.2020 um 11:05 Uhr)
https://academic.oup.com/ajcp/article/154/5/610/5893931
-
SARS-CoV-2 antibody signatures for predicting the outcome of COVID-19
(Hinzugefügt: 13.11.2020 um 15:51 Uhr)
https://www.medrxiv.org/content/10.1101/2020.11.10.20228890v1
-
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum
(Hinzugefügt: 11.11.2020 um 10:44 Uhr)
https://www.nature.com/articles/s41590-020-00826-9
-
Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases
(Hinzugefügt: 11.11.2020 um 08:31 Uhr)
https://www.sciencedirect.com/science/article/pii/S0009898120305179
-
specificity and sensitivity of SARS-CoV-2 antibody tests
(Hinzugefügt: 08.11.2020 um 11:51 Uhr)
https://www.medrxiv.org/content/10.1101/2020.11.05.20226449v1
-
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production
(Hinzugefügt: 03.11.2020 um 14:46 Uhr)
https://www.cell.com/cell/fulltext/S0092-8674(20)31458-6
-
Seroprävalenz nach 6 Monaten
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://onlinelibrary.wiley.com/doi/10.1002/eji.202048970
-
Combining PCR & Antibody
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://jamanetwork.com/journals/jama/fullarticle/2771584
-
test
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.aerzteblatt.de/nachrichten/116099/Leipziger-Forscher-entwickeln-Coronaantikoerpertest-fuer-zuhause
-
Abbott Architect, Roche Elecsys and Virtus S1
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.medrxiv.org/content/10.1101/2020.10.27.20220509v1
-
zeitlicher Verlauf Antikörper
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.aerzteblatt.de/archiv/216359/COVID-19-Impfstoffe-Zwischen-Vision-und-Illusion
-
dm- Selbsttest für zu Hause
(Hinzugefügt: 01.11.2020 um 15:56 Uhr)
https://www.wa.de/verbraucher/corona-test-dm-antikoerper-zuhause-selbsttest-coronavirus-drogeriemarkt-covid-19-sars-cov-2-aerzte-hamm-kunden-90080841.html